SEC CIK 1250252

RHOADS ANN D

Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
GMEDview stock →40,3842026-06-04
IRIXview stock →5,6902018-06-13

Position History — GMED

Reported shares owned immediately after each Form 4 transaction, over time.

019,29538,58957,8842021-032023-012024-092024-092024-092025-022025-092025-112025-112026-06

Recent Filings — GMED

DateActivitySharesPriceOwned After
2026-06-04Option exercise (derivative)25,000$0.000
2026-06-04Option exercise25,000$26.2740,384
2026-01-21Grant / award (derivative)15,000$0.0015,000
2025-11-10Open-market sale2,000$85.0015,384
2025-11-07Open-market sale8,000$81.0017,384
2025-09-15Open-market sale10,000$58.4625,384
2025-02-28Open-market sale7,500$78.6835,384
2025-01-23Grant / award (derivative)15,000$0.0015,000
2024-09-13Option exercise (derivative)15,000$0.000
2024-09-13Option exercise20,000$25.5257,884
2024-09-13Option exercise15,000$24.1037,884
2024-09-13Open-market sale15,000$70.3642,884
2024-01-26Grant / award (derivative)15,000$0.0015,000
2023-01-27Option exercise (derivative)7,500$0.000
2023-01-27Option exercise7,500$12.5922,884
2023-01-26Grant / award (derivative)15,000$0.0015,000
2022-01-27Grant / award (derivative)15,000$0.0015,000
2021-03-01Option exercise (derivative)15,384$0.000
2021-03-01Option exercise15,384$10.6615,384
2021-01-14Grant / award (derivative)15,000$0.0015,000
2020-01-22Grant / award (derivative)25,000$0.0025,000
2019-01-22Grant / award (derivative)25,000$0.0025,000
2018-01-22Grant / award (derivative)25,000$0.0025,000
2017-01-30Grant / award (derivative)25,000$0.0025,000
2016-01-25Grant / award (derivative)20,000$0.0020,000
2015-01-20Grant / award (derivative)15,000$0.0015,000
2014-01-23Grant / award (derivative)10,000$0.0010,000
2013-01-30Grant / award (derivative)7,500$0.007,500
2012-08-08J (derivative)15,384$0.0015,384

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.